XSHE
300927
Market cap590mUSD
Oct 09, Last price
27.11CNY
1D
-0.99%
1Q
27.82%
IPO
4.96%
Name
Nantong JiangTian Chemical Co Ltd
Chart & performance
P/E
200.60
P/S
2.52
EPS
0.14
Div yield, %
0.33%
Shrs. gr., 5y
0.01%
Rev. gr., 5y
16.94%
Revenues
1.55b
+125.51%
Net income
20m
-93.45%
CFO
160m
+880.59%
Dividend
Jun 23, 20260.075 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Nantong JiangTian Chemical Co., Ltd. engages in the research, development, production, and sale of fine chemicals. Its products include paraformaldehyde, formaldehyde, methyl chloride, and ethylene glycol hemiacetal. The company was founded in September 1999 and is headquartered in Nantong, China.
Key people
Hui Zhu
Chairman of the Board, General Manager · since 2022
Bin Shi
Finance Director, Deputy General Manager, Secretary of the Board · since 2022
Jianjun Ren
Deputy General Manager · since 2015
Xiaodong Sha
Deputy General Manager · since 2021
Xiang Xu
Deputy General Manager · since 2021
Yongfeng Zhang
Deputy General Manager · since 2014
Hongying Chen
Director · since 2022
Dongming Chen
Director · since 2024
Yunguang Chen
Director · since 2019
Hui Lu
Staff Elected Director · since 2025
Jinghua Xue
Director · since 2022
Yihu Song
Independent Director · since 2022
Jianxin Wu
Independent Director · since 2022
Dong Yu
Independent Director · since 2022
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2019‑00 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||||
Revenues | |||||||||||||
Cost of revenue | |||||||||||||
Unusual Expense (Income) | |||||||||||||
NOPBT | |||||||||||||
NOPBT Margin | |||||||||||||
Operating Taxes | |||||||||||||
Tax Rate | |||||||||||||
NOPAT | |||||||||||||
Net income | |||||||||||||
Dividends | |||||||||||||
Dividend yield | |||||||||||||
Proceeds from repurchase of equity | |||||||||||||
BB yield | |||||||||||||
| Debt | |||||||||||||
Debt current | |||||||||||||
Long-term debt | |||||||||||||
Deferred revenue | |||||||||||||
Other long-term liabilities | |||||||||||||
Net debt | |||||||||||||
| Cash flow | |||||||||||||
Cash from operating activities | |||||||||||||
CAPEX | |||||||||||||
Cash from investing activities | |||||||||||||
Cash from financing activities | |||||||||||||
FCF | |||||||||||||
| Balance | |||||||||||||
Cash | |||||||||||||
Long term investments | |||||||||||||
Excess cash | |||||||||||||
Stockholders' equity | |||||||||||||
Invested Capital | |||||||||||||
ROIC | |||||||||||||
ROCE | |||||||||||||
| EV | |||||||||||||
Common stock shares outstanding | |||||||||||||
Price | |||||||||||||
Market cap | |||||||||||||
EV | |||||||||||||
EBITDA | |||||||||||||
EV/EBITDA | |||||||||||||
Interest | |||||||||||||
Interest/NOPBT | |||||||||||||